Literature DB >> 7522108

Expression of adhesion molecules and c-kit on CD34+ hematopoietic progenitor cells: comparison of cytokine-mobilized blood stem cells with normal bone marrow and peripheral blood.

R Möhle1, R Haas, W Hunstein.   

Abstract

We assessed the expression of the adhesion molecules leukocyte function antigen-1 (LFA-1, CD11a), intercellular adhesion molecule-1 (ICAM-1, CD54), homing-associated cell adhesion molecule (H-CAM, CD44), and c-kit (stem cell factor receptor) on the CD34+ progenitor population from the leukapheresis products of 23 patients (LP CD34+). For blood stem cell collection granulocyte colony-stimulating factor (G-CSF) or interleukin-3/granulocyte-macrophage colony-stimulating factor (IL-3/GM-CSF) was administered after cytotoxic chemotherapy. Furthermore, bone marrow- and blood-derived CD34+ progenitor cells from 6 normal volunteers (BM and PB CD34+) were analyzed. LFA-1 expression was higher on PB CD34+ (88.2 +/- 2.5%, mean +/- SEM) than on BM CD34+ (75.3 +/- 4.3%). Following cytokine administration, LFA-1 was expressed on only 59.7 +/- 3.7% of LP CD34+ at a low fluorescence intensity, suggesting that down-regulation of LFA-1 may facilitate the egress of cells from the bone marrow and prolong their circulation. In contrast, ICAM-1 was weakly positive on CD34+ cells from all sources. CD44 was expressed on the vast majority of CD34+ cells (> 95%) in all samples studied. The highest proportion of CD34+ cells costaining for c-kit was found in normal bone marrow (32.2 +/- 3.3%). In normal peripheral blood and after cytokine mobilization, fewer of the CD34+ cells weakly expressed c-kit (< 15%). The low percentage and level of c-kit expression may indicate that the majority of cytokine-mobilized CD34+ cells are lineage-committed progenitor cells, as reflected by the coexpression pattern for CD38, HLA-DR, and CD33.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7522108     DOI: 10.1089/scd.1.1993.2.483

Source DB:  PubMed          Journal:  J Hematother        ISSN: 1061-6128


  4 in total

Review 1.  Use of filgrastim for stem cell mobilisation and transplantation in high-dose cancer chemotherapy.

Authors:  Paolo Anderlini; Richard Champlin
Journal:  Drugs       Date:  2002       Impact factor: 9.546

Review 2.  MT1-MMP and RECK: opposite and essential roles in hematopoietic stem and progenitor cell retention and migration.

Authors:  Karin Golan; Yaron Vagima; Polina Goichberg; Shiri Gur-Cohen; Tsvee Lapidot
Journal:  J Mol Med (Berl)       Date:  2011-08-13       Impact factor: 4.599

3.  The CXCR4 and adhesion molecule expression of CD34+ hematopoietic cells mobilized by "on-demand" addition of plerixafor to granulocyte-colony-stimulating factor.

Authors:  Tamara Girbl; Verena Lunzer; Richard Greil; Konrad Namberger; Tanja Nicole Hartmann
Journal:  Transfusion       Date:  2014-03-28       Impact factor: 3.157

4.  Immunohistochemical and serological evaluation of CD44 splice variants in human ovarian cancer.

Authors:  G Sliutz; C Tempfer; S Winkler; P Kohlberger; A Reinthaller; C Kainz
Journal:  Br J Cancer       Date:  1995-12       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.